Evidence map›Paper›PMID 30507330›Full record

ArticleCell cycle (Georgetown, Tex.)2018

Sustained protein synthesis and reduced eEF2K levels in TAp73

Barak Rotblat, Massimiliano Agostini, Maria Victoria Niklison-Chirou, Ivano Amelio, Anne E Willis, Gerry Melino

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Aging · 2021
    Article
  2. Article
  3. Skin immunity and its dysregulation in psoriasis.Cell cycle (Georgetown, Tex.) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Barak Rotblata MRC Toxicology Unit , University of Cambridge , Rome , UK.ORCID 0000-0003-2985-7115
Massimiliano Agostinia MRC Toxicology Unit , University of Cambridge , Rome , UK.ORCID 0000-0003-3124-2072
Maria Victoria Niklison-Chiroua MRC Toxicology Unit , University of Cambridge , Rome , UK.
Ivano Amelioa MRC Toxicology Unit , University of Cambridge , Rome , UK.
Anne E Willisa MRC Toxicology Unit , University of Cambridge , Rome , UK.
Gerry Melinoa MRC Toxicology Unit , University of Cambridge , Rome , UK.
University of Cambridge · GBUniversity of Rome Tor Vergata · ITBen-Gurion University of the Negev · ILQueen Mary University of London · GB

Funding

Medical Research Council MC_U132670600Medical Research Council MC_UP_A600_1023Medical Research Council MC_UU_00025/2Medical Research Council MC_UU_00025/7
6 · The paper itself

Abstract

The transcription factor p73 is a member of the p53 family, of which the transactivation domain containing isoform (TAp73) plays key roles in brain development and neuronal stem cells. TAp73 also facilitates homoeostasis and prevents oxidative damage in vivo by inducing the expression of its target genes. Recently, we found that in addition to its role in regulation of transcription, TAp73 also affects mRNA translation. In cultured cells, acute TAp73 depletion activates eEF2K, which phosphorylates eEF2 reducing mRNA translation elongation. As a consequence, there is a reduction in global proteins synthesis rates and reprogramming of the translatome, leading to a selective decrease in the translation of rRNA processing factors. Given the dramatic effects of Tap73 depletion in vitro it was important to determine whether similar effects were observed in vivo. Here, we report the surprising finding that in brains of TAp73 KO mice there is a reduced level of eEF2K, which allows protein synthesis rates to be maintained suggesting a compensation model. These data provide new insights to the role of TAp73 in translation regulation and the eEF2K pathway in the brain.

Indexed as

AnimalsBrainDown-RegulationElongation Factor 2 KinaseMiceMice, KnockoutPhosphorylationProtein BiosynthesisTumor Protein p73Eef2k protein, mouseElongation Factor 2 KinaseTumor Protein p73neuronal developmentprotein+synthesis and p53+family

Identifiers

PMID30507330
PMCPMC6300112
OpenAlexW2902802343

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.